UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 94 filers reported holding ANTARES PHARMA INC in Q3 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$711,096,000
+16.4%
173,438
+1.3%
0.00%
Q4 2021$611,023,000
+0.2%
171,155
+2.1%
0.00%
Q3 2021$610,064,000
-15.6%
167,600
+1.0%
0.00%
Q2 2021$723,193,000
+6.7%
165,870
+0.6%
0.00%
Q1 2021$677,953,000
+8.8%
164,952
+5.6%
0.00%
Q4 2020$623,046,000
+47.8%
156,1520.0%0.00%
Q3 2020$421,610,000
-1.8%
156,1520.0%0.00%
Q2 2020$429,418,000
+6.1%
156,152
-8.9%
0.00%
Q1 2020$404,549,000
-46.6%
171,419
+6.3%
0.00%
Q4 2019$757,715,000
+116.2%
161,216
+53.9%
0.00%
Q3 2019$350,440,000
+112.7%
104,765
+109.2%
0.00%
Q2 2019$164,776,000
+8.6%
50,0840.0%0.00%
Q1 2019$151,755,000
+23.5%
50,084
+10.8%
0.00%
Q4 2018$122,900,000
+114759.8%
45,184
-28.4%
0.00%
Q3 2015$107,000
-18.3%
63,0960.0%0.00%
Q2 2015$131,000
-19.1%
63,096
+5.9%
0.00%
Q1 2015$162,000
+12.5%
59,596
+6.6%
0.00%
Q4 2014$144,000
+41.2%
55,8960.0%0.00%
Q3 2014$102,000
-96.3%
55,896
-94.5%
0.00%
-100.0%
Q2 2014$2,727,000
-30.9%
1,021,296
-9.4%
0.00%
-25.0%
Q1 2014$3,947,000
+0.8%
1,127,596
+29.0%
0.00%0.0%
Q4 2013$3,916,000
+5.3%
874,296
-4.6%
0.00%
-20.0%
Q3 2013$3,720,000
+0.9%
916,296
+3.4%
0.01%0.0%
Q2 2013$3,687,000886,1960.01%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
WILLIAM HARRIS INVESTORS INC 2,338,735$6,244,0001.73%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,603,703$25,642,0001.03%
Broadfin Capital, LLC 6,100,000$16,288,0000.80%
ASHFORD CAPITAL MANAGEMENT INC 1,088,675$2,907,0000.58%
MARINER INVESTMENT GROUP LLC 296,477$792,0000.15%
THOMPSON DAVIS & CO., INC. 36,500$97,0000.14%
Peregrine Asset Advisers, Inc. 53,034$142,0000.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,165,738$3,101,0000.12%
Avenir Corp 341,035$911,0000.08%
Brown Advisory Securities, LLC 50,550$135,0000.05%
View complete list of ANTARES PHARMA INC shareholders